NDC 25021-254 – Docetaxel
Docetaxel Anhydrous 10 mg/mL · Injection · Intravenous
Product NDC25021-254
Product details
- Brand name
- Docetaxel
- Generic name
- Docetaxel Anhydrous
- Labeler
- Sagent Pharmaceuticals
- Dosage form
- Injection
- Route
- Intravenous
- Marketing category
- ANDA · ANDA213510
- Marketed since
- August 1, 2023
- Listing expires
- December 31, 2026
- Pharmacologic class
- Microtubule Inhibitor
Active ingredients
- Docetaxel Anhydrous 10 mg/mL
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 25021-254-08 | 1 VIAL in 1 CARTON (25021-254-08) / 8 mL in 1 VIAL | Aug 1, 2023 |
| 25021-254-16 | 1 VIAL in 1 CARTON (25021-254-16) / 16 mL in 1 VIAL | Aug 1, 2023 |
Recalls mentioning this NDC
- D-0554-2024 Jun 19, 2024 · Class I
Presence of Particulate Matter: Presence of particulate matter from the stopper in the drug product. - D-0553-2024 Jun 19, 2024 · Class I
Presence of Particulate Matter: Presence of particulate matter from the stopper in the drug product.
Other Docetaxel products
- 62332-678 Docetaxel Anhydrous 10 mg/mL · Injection · Alembic Pharmaceuticals Inc.
- 46708-678 Docetaxel Anhydrous 10 mg/mL · Injection · Alembic Pharmaceuticals Limited
- 70121-1221 Docetaxel Anhydrous 20 mg/mL · Injection · Amneal Pharmaceuticals LLC
- 70121-1223 Docetaxel Anhydrous 160 mg/8mL · Injection · Amneal Pharmaceuticals LLC
- 70121-1222 Docetaxel Anhydrous 80 mg/4mL · Injection · Amneal Pharmaceuticals LLC
- 43066-048 Docetaxel Anhydrous 10 mg/mL · Injection · Baxter Healthcare Corporation
- 43066-046 Docetaxel Anhydrous 10 mg/mL · Injection · Baxter Healthcare Corporation
- 43066-044 Docetaxel Anhydrous 10 mg/mL · Injection · Baxter Healthcare Corporation
- 68083-401 Docetaxel Anhydrous 10 mg/mL · Injection · Gland Pharma Limited
- 68083-400 Docetaxel Anhydrous 10 mg/mL · Injection · Gland Pharma Limited
- 68083-399 Docetaxel Anhydrous 10 mg/mL · Injection · Gland Pharma Limited
- 23155-905 Docetaxel 160 mg/8mL · Injection · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.